Demant A/S provided earnings guidance for the full year 2022. For the year, the company expected Organic growth of 5-9% and EBIT DKK 3,600 million - DKK 3,900 million. Profit after tax from discontinued operations Negative by DKK 150 million - DKK 200 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
320.8 DKK | -0.62% | +2.23% | +8.38% |
Apr. 08 | Denmark's Demant Finalizes Capital Reduction | MT |
Apr. 04 | Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.38% | 10.01B | |
+1.11% | 23.92B | |
-7.00% | 16.65B | |
+7.14% | 13.6B | |
-19.75% | 2.01B | |
+12.20% | 1.88B | |
+34.84% | 1.67B | |
0.00% | 492M | |
+31.01% | 139M | |
+34.50% | 104M |
- Stock Market
- Equities
- DEMANT Stock
- News Demant A/S
- Demant A/S Provides Earnings Guidance for the Full Year 2022